Reproducibility of Serologic Assays for Influenza Virus A (H5N1)

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)

Hemagglutination-inhibition (HI) and neutralization are used to evaluate vaccines against influenza virus A (H5N1); however, poor standardization leads to interlaboratory variation of results. A candidate antibody standard (07/150) was prepared from pooled plasma of persons given clade 1 A/Vietnam/1...

Full description

Bibliographic Details
Main Authors: Iain Stephenson, Alan Heath, Diane Major, Robert W. Newman, Katja Hoschler, Wang Junzi, Jacqueline M. Katz, Jerry P. Weir, Maria C. Zambon, John M. Wood
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2009-08-01
Series:Emerging Infectious Diseases
Subjects:
pandemic
vaccine
immunogenicity
influenza
viruses
serologic assays
Online Access:https://wwwnc.cdc.gov/eid/article/15/8/08-1754_article

Internet

https://wwwnc.cdc.gov/eid/article/15/8/08-1754_article

Similar Items